NCT06954181View on ClinicalTrials.gov

Quantification of Diclofenac 2.32% (Voltaren) in Rinse Water After Different Application Methods

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

March 26, 2025

Primary Completion Date

April 11, 2025

Study Completion Date

April 11, 2025

Conditions
Healthy Participants
Interventions
DRUG

Voltaren® Schmerzgel forte; 2.32% (Test Product)

Voltaren® Schmerzgel forte; 2.32% containing 2.32% Diclofenac-N-Ethylethanamin.

Trial Locations (1)

22869

SGS proderm GmbH, Schenefeld

All Listed Sponsors
lead

HALEON

INDUSTRY